4//SEC Filing
SELANDER ROBERT W 4
Accession 0001415889-25-003701
CIK 0001428336other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 12:33 PM ET
Size
11.2 KB
Accession
0001415889-25-003701
Insider Transaction Report
Form 4
SELANDER ROBERT W
Director
Transactions
- Exercise/Conversion
Common Stock
2025-02-10$28.68/sh+12,500$358,500→ 83,969 total - Sale
Common Stock
2025-02-10$110.98/sh−3,752$416,407→ 80,217 total - Sale
Common Stock
2025-02-10$111.87/sh−1,998$223,520→ 78,219 total - Exercise/Conversion
Stock Option (right to buy)
2025-02-10−12,500→ 12,500 totalExercise: $28.68Exp: 2025-09-29→ Common Stock (12,500 underlying)
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on July 09, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.62 to $111.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) and (3) of this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.62 to $112.50, inclusive.
- [F4]The option is immediately exercisable.
Documents
Issuer
HEALTHEQUITY, INC.
CIK 0001428336
Entity typeother
Related Parties
1- filerCIK 0001160228
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 12:33 PM ET
- Size
- 11.2 KB